Troubling blind spots in understanding cancer risks among transgender patients: Bias, discrimination, and a lack of good data may be impeding cancer screening and risk assessments for the transgender population. In this article, the second of a 2-part series, we explore the remaining gaps in understanding and communicating the risks.